Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection.
COVID-19
SARS-CoV-2
long-term outcomes
post COVID-19 condition
sequelae
Journal
Journal of internal medicine
ISSN: 1365-2796
Titre abrégé: J Intern Med
Pays: England
ID NLM: 8904841
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
pubmed:
9
12
2022
medline:
5
1
2023
entrez:
8
12
2022
Statut:
ppublish
Résumé
The occurrence and healthcare use trajectory of post COVID-19 condition (PCC) is poorly understood. Our aim was to investigate these aspects in SARS-CoV-2-positive individuals with and without a PCC diagnosis. We conducted a population-based cohort study of adults in Stockholm, Sweden, with a verified infection from 1 March 2020 to 31 July 2021, stratified by the severity of the acute infection. The outcome was a PCC diagnosis registered any time 90-360 days after a positive test. We performed Cox regression models to assess baseline characteristics associated with the PCC diagnosis. Individuals diagnosed with PCC were then propensity-score matched to individuals without a diagnosis to assess healthcare use beyond the acute infection. Among 204,805 SARS-CoV-2-positive individuals, the proportion receiving a PCC diagnosis was 1% among individuals not hospitalized for their COVID-19 infection, 6% among hospitalized, and 32% among intensive care unit (ICU)-treated individuals. The most common new-onset symptom diagnosis codes among individuals with a PCC diagnosis were fatigue (29%) among nonhospitalized and dyspnea among both hospitalized (25%) and ICU-treated (41%) individuals. Female sex was associated with a PCC diagnosis among nonhospitalized and hospitalized individuals, with interactions between age and sex. Previous mental health disorders and asthma were associated with a PCC diagnosis among nonhospitalized and hospitalized individuals. Among individuals with a PCC diagnosis, the monthly proportion with outpatient care was substantially elevated up to 1 year after acute infection compared to before, with substantial proportions of this care attributed to PCC-related care. The differential association of age, sex, comorbidities, and healthcare use with the severity of the acute infection indicates different trajectories and phenotypes of PCC, with incomplete resolution 1 year after infection.
Sections du résumé
BACKGROUND
The occurrence and healthcare use trajectory of post COVID-19 condition (PCC) is poorly understood. Our aim was to investigate these aspects in SARS-CoV-2-positive individuals with and without a PCC diagnosis.
METHODS
We conducted a population-based cohort study of adults in Stockholm, Sweden, with a verified infection from 1 March 2020 to 31 July 2021, stratified by the severity of the acute infection. The outcome was a PCC diagnosis registered any time 90-360 days after a positive test. We performed Cox regression models to assess baseline characteristics associated with the PCC diagnosis. Individuals diagnosed with PCC were then propensity-score matched to individuals without a diagnosis to assess healthcare use beyond the acute infection.
RESULTS
Among 204,805 SARS-CoV-2-positive individuals, the proportion receiving a PCC diagnosis was 1% among individuals not hospitalized for their COVID-19 infection, 6% among hospitalized, and 32% among intensive care unit (ICU)-treated individuals. The most common new-onset symptom diagnosis codes among individuals with a PCC diagnosis were fatigue (29%) among nonhospitalized and dyspnea among both hospitalized (25%) and ICU-treated (41%) individuals. Female sex was associated with a PCC diagnosis among nonhospitalized and hospitalized individuals, with interactions between age and sex. Previous mental health disorders and asthma were associated with a PCC diagnosis among nonhospitalized and hospitalized individuals. Among individuals with a PCC diagnosis, the monthly proportion with outpatient care was substantially elevated up to 1 year after acute infection compared to before, with substantial proportions of this care attributed to PCC-related care.
CONCLUSION
The differential association of age, sex, comorbidities, and healthcare use with the severity of the acute infection indicates different trajectories and phenotypes of PCC, with incomplete resolution 1 year after infection.
Identifiants
pubmed: 36478477
doi: 10.1111/joim.13584
pmc: PMC9877994
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
246-258Informations de copyright
© 2022 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
Références
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
BMC Med. 2021 Sep 27;19(1):249
pubmed: 34565368
JAMA. 2022 Feb 08;327(6):559-565
pubmed: 35072716
J Intern Med. 2023 Feb;293(2):246-258
pubmed: 36478477
Crit Care Med. 2018 Sep;46(9):1393-1401
pubmed: 29787415
Lancet Infect Dis. 2022 Apr;22(4):e102-e107
pubmed: 34951953
Euro Surveill. 2006;11(5):103-7
pubmed: 16757847
Lancet Respir Med. 2022 Aug;10(8):761-775
pubmed: 35472304
BMJ Glob Health. 2021 Sep;6(9):
pubmed: 34580069
Lancet Reg Health Eur. 2021 Dec;11:100242
pubmed: 34746909
BMC Public Health. 2013 Jul 18;13:670
pubmed: 23866784
J Intern Med. 2022 Jul;292(1):168-171
pubmed: 35253283
EBioMedicine. 2021 Dec;74:103722
pubmed: 34839263
BMJ. 2021 Jul 26;374:n1648
pubmed: 34312178
Lancet Reg Health Eur. 2021 Sep;8:100186
pubmed: 34386785
Nat Commun. 2020 Oct 9;11(1):5097
pubmed: 33037218
BMJ. 2022 Jan 17;376:e066809
pubmed: 35039315
Nat Commun. 2021 Nov 12;12(1):6571
pubmed: 34772922
Br J Anaesth. 2021 Jun;126(6):e217-e219
pubmed: 33812669
Nat Commun. 2022 Apr 12;13(1):1957
pubmed: 35413949
Lancet Infect Dis. 2021 Oct;21(10):1373-1382
pubmed: 33984263
PLoS Med. 2021 Sep 28;18(9):e1003773
pubmed: 34582441
Eur Heart J. 2022 Mar 14;43(11):1157-1172
pubmed: 35176758
Annu Rev Public Health. 2018 Apr 1;39:453-469
pubmed: 29328877
Crit Care. 2021 Feb 25;25(1):86
pubmed: 33632273
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
Fam Pract. 2013 Oct;30(5):506-13
pubmed: 23825186
Lancet Public Health. 2022 May;7(5):e406-e416
pubmed: 35298894
BMJ. 2021 Dec 29;375:e065834
pubmed: 34965929
Nat Commun. 2022 Apr 5;13(1):1812
pubmed: 35383197